Citigroup Issues Positive Forecast for Insulet (NASDAQ:PODD) Stock Price
Insulet (NASDAQ:PODD – Get Free Report) had its price target boosted by equities researchers at Citigroup from $310.00 to $355.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the medical instruments supplier’s stock. Citigroup’s target price points to a potential upside of 25.53% from the stock’s […]
Insulet (NASDAQ:PODD – Get Free Report) had its price target boosted by equities researchers at Citigroup from $310.00 to $355.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the medical instruments supplier’s stock. Citigroup’s target price points to a potential upside of 25.53% from the stock’s […]
